Year |
Citation |
Score |
2016 |
Chang SW, McDonough CW, Gong Y, Johnson TA, Tsunoda T, Gamazon ER, Perera MA, Takahashi A, Tanaka T, Kubo M, Pepine CJ, Johnson JA, Cooper-DeHoff RM. Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. The Pharmacogenomics Journal. PMID 27670767 DOI: 10.1038/tpj.2016.67 |
0.32 |
|
2016 |
Chang SW, Gong Y, McDonough CW, Langaee TY, Nasiri Kenari N, Beitelshees AL, Gums JG, Chapman AB, Turner ST, Johnson JA, Cooper-DeHoff RM. Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation? Clinical and Translational Science. PMID 26946962 DOI: 10.1111/cts.12389 |
0.4 |
|
2013 |
McDonough CW, Gillis NK, Alsultan A, Chang SW, Kawaguchi-Suzuki M, Lang JE, Shahin MH, Buford TW, El Rouby NM, Sá AC, Langaee TY, Gums JG, Chapman AB, Cooper-DeHoff RM, Turner ST, et al. Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. Plos One. 8: e76984. PMID 24116192 DOI: 10.1371/journal.pone.0076984 |
0.32 |
|
2013 |
Karnes JH, Langaee TY, McDonough CW, Chang SW, Ramos M, Catlin JR, Casanova OE, Gong Y, Pepine CJ, Johnson JA, Cooper-Dehoff RM. Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort. Journal of Translational Medicine. 11: 12. PMID 23302499 DOI: 10.1186/1479-5876-11-12 |
0.32 |
|
Show low-probability matches. |